Trevena to Release Fourth Quarter and Full Year 2020 Financial Results

Trevena

CHESTERBROOK, PA — Trevena, Inc. (Nasdaq: TRVN) announced that it will release its financial results for the fourth quarter and full year ended December 31, 2020, prior to the market open on Tuesday, March 9th, 2021.

The Company will host a conference call and webcast with the investment community at 8:00 a.m. ET that same day, featuring remarks by Carrie Bourdow, President and Chief Executive Officer, Bob Yoder, SVP and Chief Commercial Officer, Mark Demitrack, M.D., SVP and Chief Medical Officer, and Barry Shin, SVP and Chief Financial Officer.

Additionally, Dr. Gregory Hammer, Professor of Anesthesiology, Stanford University Medical Center, will be providing additional remarks on the role of OLINVYK™ (oliceridine) injection in acute pain management and key considerations in the formulary review process at his institution.

Title: Trevena Fourth Quarter & Full Year 2020 Financial Results Conference Call & Webcast
Date: Tuesday, March 9, 2021
Time: 8:00 a.m. ET
Conference Call Details: Toll-Free: 855-465-0180
International: 484-756-4313
Conference ID: 7276985
Webcast: https://edge.media-server.com/mmc/p/z467y594

READ:  UGI Corporation to Hold 2QFY21 Earnings Conference Call and Webcast

The webcast will be available starting 15 minutes prior to the conference call start time. A replay of the webcast will be accessible following the conclusion of the live broadcast on the company’s website at https://www.trevena.com/investors/events-presentations/ir-calendar.

The Company today also announced that Carrie Bourdow will participate on a panel hosted by Scott Gottlieb, M.D., Former FDA Commissioner (2017-2019), as part of the H.C. Wainwright Global Life Sciences Virtual Conference. Additional details are below:

Title: Reimbursement and Pricing – Pre- and Post-Commercialization Considerations
Date: Tuesday, March 9, 2021
Time: 1:00 p.m. ET
Webcast: https://journey.ct.events/view/77c19841-d2aa-433e-8447-a47e4dde66de

Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with CNS disorders.

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.

Buy Us a Cup of Coffee